Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 6, 2020

Gilead Sciences gets EC conditional approval for Veklury to treat Covid-19 disease

Gilead Sciences has secured conditional marketing authorisation from the European Commission for its Veklury (remdesivir) to treat SARS-CoV-2 infection, which is responsible for the Covid-19 disease.

Continue
Gilead Sciences has secured EC conditional approval for Veklury to treat Covid-19 disease. (Credit: fernando zhiminaicela from Pixabay)
July 6, 2020

Ascentage, MSD to study APG-115, KEYTRUDA combo in advanced solid tumours

APG-115, KEYTRUDA combo to be studied in advanced solid tumours. (Credit: Merck Sharp & Dohme Corp.)
July 3, 2020

ViiV Healthcare gets FDA nod for HIV drug Rukobia to treat adult patients

ViiV Healthcare’s Rukobia product. (Credit: Business Wire)

Contracts

May 15, 2020

Takeda gets expanded EC approval for lymphoma drug Adcetris

The head office of Takeda Pharmaceutical Company, in Chuo-ku, Osaka, Japan. (Courtesy of J o / Wikimedia Commons)

Concert Pharmaceuticals announces plans for CTP-543 phase 3 trials in alopecia areata

ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

Deals

Deals June 29, 2020

Carlyle Group to acquire 20% stake in India-based Piramal Pharma for $490m

Pharmaceutical Business Review

Gilead Sciences to buy 49.9% stake in Pionyr Immunotherapeutics for $275m

Piramal acquires solid oral dosage drug product facility in US from G&W

SC formulation of DARZALEX combination delivers deep and rapid haematologic responses and improved clinical outcomes in newly diagnosed light chain amyloidosis

Popular

  1. Janssen gets EC approval for Ebola vaccine regimen
  2. Roche gets FDA nod for Phesgo to treat HER2-positive breast cancer
  3. Theravance Biopharma doses first patient in phase 2 Covid-19 trial with JAKi inhibitor TD-0903
  4. NeuroRx, Relief Therapeutics secure FDA fast track status for Covid-19 drug candidate
  5. India’s Cipla launches remdesivir generic version to treat Covid-19 disease

PRESS RELEASES

Rentschler Biopharma and Vetter Team Up with Joint Goal to Simplify Processes and Optimize Time-to-Market
Rentschler Biopharma and Vetter Team Up with Joint Goal to Simplify Processes and Optimize Time-to-Market
CBDepot Group Announces New EU GMP Compliant Manufacturing Site for Cannabidiol APIs
CBDepot Group Announces New EU GMP Compliant Manufacturing Site for Cannabidiol APIs
Pharmaceutical Business Review
NSF Launches New IVD App
NSF to Host Webinar on Trial Design in General & Adaptive Trials
NSF to Host Webinar on Trial Design in General & Adaptive Trials
Novel Coronavirus Antibody Detection Reagent in Development at Tosoh
Novel Coronavirus Antibody Detection Reagent in Development at Tosoh

Suppliers

Whitepapers

Low Maintenance pH Electrodes and Systems
Low Maintenance pH Electrodes and Systems
Elemental Packaging
Elemental Packaging
Cannabinoid Purification and Scale-Up on Hipersep<sup>®</sup> Pilot
Cannabinoid Purification and Scale-Up on Hipersep® Pilot